Credit: Natali _ Mis/Shutterstock. ReCode Therapeutics is set to secure up to $15m in additional funding from the Cystic Fibrosis Foundation to enhance its gene correction research programme. The ...
People with cystic fibrosis (CF) have higher chloride levels due to a genetic defect that disrupts this process. The sweat test is usually recommended for newborns with abnormal screening results ...
Dr. Albritton is a resident physician and Dr. Kingdom is Assistant Professor in the Department of Otolaryngology at Emory University School of Medicine, Atlanta, Ga. Albritton FD, Kingdom TT.
The Gateway Chapter of the Cystic Fibrosis Foundation welcomes you! Volunteers are the key to our success and the lifeblood of our organization. We have many opportunities for you to get involved.
all her wit and intelligence and personality — not just that one glitch on chromosome 7 that causes cystic fibrosis. This child would not be defined by that spin of the genetic lottery.
In the three years before he started taking an expensive new drug for his cystic fibrosis, Jeremie Saunders could feel his health failing in ways he knew would cut his life short. The Halifax ...
Nov 4 (Reuters) - Vertex Pharmaceuticals (VRTX.O), opens new tab raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF ...
Coming off of a strong third quarter, Vertex Pharmaceuticals is nearing several important milestones, including the potential approvals of vanzacaftor triple in cystic fibrosis and the non-opioid ...
Vertex’s lead cystic fibrosis treatment Trikafta (elexacaftor ... according to an analysis by GlobalData’s Pharma Intelligence Centre. GlobalData is the parent company of Pharmaceutical ...
The Cystic Fibrosis Foundation is funding the development of a gene editing therapy that is designed to use ReCode’s tissue-specific delivery vehicle to transport gene editing cargo to the lung cells ...